0 Cases of Ebola confirmed in Uganda
The Ministry of Health and WHO have reported the first case of Ebola confirmed in Uganda during the outbreak in neighbouring Democratic Republic of the Congo.
Browsing: Emerging Disease
0 Emerging technologies to investigate coronavirus emergence – an interview with Vineet Menachery
In this interview we speak to Vineet Menachery about his recent talk at the Microbiology Society’s Annual Conference (8–11 April, Belfast, UK) suggesting that CoV emergence is more complicated than receptor binding alone.
0 ECCMID19: Immune response to Ebola 2 years post-infection could provide clues for vaccine development
Two years after Ebola infection, survivors exhibit specific memory T cell responses against ebolavirus, according to new research presented at ECCMID.
0 Bombali ebolavirus discovered in bats in Kenya
A recently discovered species of the ebolavirus, the Bombali virus, has been identified in bats in Kenya, marking the first time any ebolavirus has been found in wildlife on the east coast of Africa.
0 Phase III study of Novavax’s RSV vaccine fails primary objective: March’s industry headlines
Take a look at this month’s industry headlines including news on Sanofi’s Dengvaxia® vaccine from the USA and the Philippines, clinical trial results for RSV vaccines and HIV injectables and new acquisitions for Merck.
0 Institutional trust and misinformation: the impact on Ebola control efforts
A new population-based survey has reported that low levels of public trust could have impacted the Ebola control efforts in the Democratic Republic of Congo, with a quarter of individuals not believing the virus was real and refusing vaccination.
0 Rising vector-borne diseases result from Venezuela’s ongoing crisis
A review of Venezuela’s current crisis has given cause for concern, highlighting the increased rate of re-emergence and spread of vector-borne diseases such as malaria, Chagas disease, dengue and Zika virus.
0 Mayaro virus: novel synthetic DNA vaccine provides immunity in preclinical trials
Researchers from the Wistar Institute have engineered a synthetic DNA vaccine able to provide potent immunity against the emerging Mayaro virus in mice models.
0 Takeda’s dengue vaccine meets primary endpoint in Phase III: January’s industry headlines
Take a look at this month’s industry headlines including an FDA approval for a vaccine protecting against six diseases, positive clinical trial results for bacteraemia and dengue vaccines and new funding for CRSIPR-based antimicrobials.
0 Madariaga virus identified in Haiti
Madariaga virus has been identified as the cause of acute febrile illness in eight children in Haiti between 2015 and 2016 – the first time it has been discovered in the country.
